APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Retinal Disorders Therapy

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Retinal Disorders Therapy Industry Growth and Trends Forecast to 2032

Report ID 174032590119 December 2025113 pages

Choose your research edition.

Industry ResearchRetinal Disorders Therapy Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Retinal Disorders Therapy Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Retinal Disorders Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Retinal Disorders Therapy Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Retinal Disorders Therapy Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

According to APO Research, the global Retinal Disorders Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Retinal Disorders Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Retinal Disorders Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Retinal Disorders Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Retinal Disorders Therapy market include ALLERGAN, Alimera Sciences, Bausch & Lomb, Bristol-Myers Squibb, Genentech, Genzyme, Janssen Biotech, OCULAR THERAPEUTIX and Swedish Orphan Biovitrum, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Retinal Disorders Therapy market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Retinal Disorders Therapy market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Retinal Disorders Therapy market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Retinal Disorders Therapy.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Retinal Disorders Therapy market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Retinal Disorders Therapy Market by Company

ALLERGAN

Alimera Sciences

Bausch & Lomb

Bristol-Myers Squibb

Genentech

Genzyme

Janssen Biotech

OCULAR THERAPEUTIX

Swedish Orphan Biovitrum

UCBCares

AbbVie

Eyebright Medical

Aier Eye Hospital

Alcon Holdings, Inc.

Huaxia Eye Hospital

Kanghong Pharmaceutical

Roche

Xingqi Pharmaceutical

Retinal Disorders Therapy Segment by Type

Ocular Inflammatory Disease (Uveitis)

Diabetic Retinopathy

Age Related Macular Degeneration

Macular Hole

Retinal Disorders Therapy Segment by Application

Hospitals

Clinics

Others

Retinal Disorders Therapy Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Retinal Disorders Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Retinal Disorders Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Retinal Disorders Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Retinal Disorders Therapy companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Retinal Disorders Therapy Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Retinal Disorders Therapy Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Retinal Disorders Therapy Market Share by Region (2021-2026) Table 4. Global Retinal Disorders Therapy Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Retinal Disorders Therapy Market Share by Region (2027-2032) Table 6. Global Retinal Disorders Therapy Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Retinal Disorders Therapy Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Retinal Disorders Therapy Market Size Share by Type (2021-2026) Table 9. Global Retinal Disorders Therapy Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Retinal Disorders Therapy Market Size Share Forecasted by Type (2027-2032) Table 11. North America Retinal Disorders Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Retinal Disorders Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Retinal Disorders Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Retinal Disorders Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Retinal Disorders Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Retinal Disorders Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Retinal Disorders Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Retinal Disorders Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Retinal Disorders Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Retinal Disorders Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Retinal Disorders Therapy Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Retinal Disorders Therapy Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Retinal Disorders Therapy Market Size Share by Application (2021-2026) Table 24. Global Retinal Disorders Therapy Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Retinal Disorders Therapy Market Size Share Forecasted by Application (2027-2032) Table 26. North America Retinal Disorders Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Retinal Disorders Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Retinal Disorders Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Retinal Disorders Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Retinal Disorders Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Retinal Disorders Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Retinal Disorders Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Retinal Disorders Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Retinal Disorders Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Retinal Disorders Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Retinal Disorders Therapy Industry Trends Table 37. Retinal Disorders Therapy Industry Drivers Table 38. Retinal Disorders Therapy Industry Opportunities and Challenges Table 39. Retinal Disorders Therapy Industry Restraints Table 40. Global Retinal Disorders Therapy Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Retinal Disorders Therapy Revenue Market Share by Company (2021-2026) Table 42. Global Retinal Disorders Therapy Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Retinal Disorders Therapy Key Company Headquarters & Area Served Table 44. Global Retinal Disorders Therapy Company, Product Type & Application Table 45. Global Retinal Disorders Therapy Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Retinal Disorders Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. ALLERGAN Company Information Table 49. ALLERGAN Business Overview Table 50. ALLERGAN Retinal Disorders Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. ALLERGAN Retinal Disorders Therapy Product Portfolio Table 52. ALLERGAN Recent Development Table 53. Alimera Sciences Company Information Table 54. Alimera Sciences Business Overview Table 55. Alimera Sciences Retinal Disorders Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Alimera Sciences Retinal Disorders Therapy Product Portfolio Table 57. Alimera Sciences Recent Development Table 58. Bausch & Lomb Company Information Table 59. Bausch & Lomb Business Overview Table 60. Bausch & Lomb Retinal Disorders Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Bausch & Lomb Retinal Disorders Therapy Product Portfolio Table 62. Bausch & Lomb Recent Development Table 63. Bristol-Myers Squibb Company Information Table 64. Bristol-Myers Squibb Business Overview Table 65. Bristol-Myers Squibb Retinal Disorders Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Bristol-Myers Squibb Retinal Disorders Therapy Product Portfolio Table 67. Bristol-Myers Squibb Recent Development Table 68. Genentech Company Information Table 69. Genentech Business Overview Table 70. Genentech Retinal Disorders Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Genentech Retinal Disorders Therapy Product Portfolio Table 72. Genentech Recent Development Table 73. Genzyme Company Information Table 74. Genzyme Business Overview Table 75. Genzyme Retinal Disorders Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Genzyme Retinal Disorders Therapy Product Portfolio Table 77. Genzyme Recent Development Table 78. Janssen Biotech Company Information Table 79. Janssen Biotech Business Overview Table 80. Janssen Biotech Retinal Disorders Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Janssen Biotech Retinal Disorders Therapy Product Portfolio Table 82. Janssen Biotech Recent Development Table 83. OCULAR THERAPEUTIX Company Information Table 84. OCULAR THERAPEUTIX Business Overview Table 85. OCULAR THERAPEUTIX Retinal Disorders Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. OCULAR THERAPEUTIX Retinal Disorders Therapy Product Portfolio Table 87. OCULAR THERAPEUTIX Recent Development Table 88. Swedish Orphan Biovitrum Company Information Table 89. Swedish Orphan Biovitrum Business Overview Table 90. Swedish Orphan Biovitrum Retinal Disorders Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Swedish Orphan Biovitrum Retinal Disorders Therapy Product Portfolio Table 92. Swedish Orphan Biovitrum Recent Development Table 93. UCBCares Company Information Table 94. UCBCares Business Overview Table 95. UCBCares Retinal Disorders Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. UCBCares Retinal Disorders Therapy Product Portfolio Table 97. UCBCares Recent Development Table 98. AbbVie Company Information Table 99. AbbVie Business Overview Table 100. AbbVie Retinal Disorders Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. AbbVie Retinal Disorders Therapy Product Portfolio Table 102. AbbVie Recent Development Table 103. Eyebright Medical Company Information Table 104. Eyebright Medical Business Overview Table 105. Eyebright Medical Retinal Disorders Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Eyebright Medical Retinal Disorders Therapy Product Portfolio Table 107. Eyebright Medical Recent Development Table 108. Aier Eye Hospital Company Information Table 109. Aier Eye Hospital Business Overview Table 110. Aier Eye Hospital Retinal Disorders Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Aier Eye Hospital Retinal Disorders Therapy Product Portfolio Table 112. Aier Eye Hospital Recent Development Table 113. Alcon Holdings, Inc. Company Information Table 114. Alcon Holdings, Inc. Business Overview Table 115. Alcon Holdings, Inc. Retinal Disorders Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Alcon Holdings, Inc. Retinal Disorders Therapy Product Portfolio Table 117. Alcon Holdings, Inc. Recent Development Table 118. Huaxia Eye Hospital Company Information Table 119. Huaxia Eye Hospital Business Overview Table 120. Huaxia Eye Hospital Retinal Disorders Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Huaxia Eye Hospital Retinal Disorders Therapy Product Portfolio Table 122. Huaxia Eye Hospital Recent Development Table 123. Kanghong Pharmaceutical Company Information Table 124. Kanghong Pharmaceutical Business Overview Table 125. Kanghong Pharmaceutical Retinal Disorders Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Kanghong Pharmaceutical Retinal Disorders Therapy Product Portfolio Table 127. Kanghong Pharmaceutical Recent Development Table 128. Roche Company Information Table 129. Roche Business Overview Table 130. Roche Retinal Disorders Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Roche Retinal Disorders Therapy Product Portfolio Table 132. Roche Recent Development Table 133. Xingqi Pharmaceutical Company Information Table 134. Xingqi Pharmaceutical Business Overview Table 135. Xingqi Pharmaceutical Retinal Disorders Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Xingqi Pharmaceutical Retinal Disorders Therapy Product Portfolio Table 137. Xingqi Pharmaceutical Recent Development Table 138. North America Retinal Disorders Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Retinal Disorders Therapy Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Retinal Disorders Therapy Market Share by Country (2021-2026) Table 141. North America Retinal Disorders Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Retinal Disorders Therapy Market Share Forecast by Country (2027-2032) Table 143. Europe Retinal Disorders Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Retinal Disorders Therapy Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Retinal Disorders Therapy Market Share by Country (2021-2026) Table 146. Europe Retinal Disorders Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Retinal Disorders Therapy Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Retinal Disorders Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Retinal Disorders Therapy Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Retinal Disorders Therapy Market Share by Country (2021-2026) Table 151. Asia-Pacific Retinal Disorders Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Retinal Disorders Therapy Market Share Forecast by Country (2027-2032) Table 153. Latin America Retinal Disorders Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Retinal Disorders Therapy Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Retinal Disorders Therapy Market Share by Country (2021-2026) Table 156. Latin America Retinal Disorders Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Retinal Disorders Therapy Market Share Forecast by Country (2027-2032) Table 158. Middle East & Africa Retinal Disorders Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East & Africa Retinal Disorders Therapy Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East & Africa Retinal Disorders Therapy Market Share by Country (2021-2026) Table 161. Middle East & Africa Retinal Disorders Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East & Africa Retinal Disorders Therapy Market Share Forecast by Country (2027-2032) Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Retinal Disorders Therapy Product Image Figure 3. Global Retinal Disorders Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Retinal Disorders Therapy Market Size (2021-2032) & (US$ Million) Figure 5. Global Retinal Disorders Therapy Market Share by Region: 2025 VS 2032 Figure 6. Global Retinal Disorders Therapy Market Share by Region (2021-2032) Figure 7. North America Retinal Disorders Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Retinal Disorders Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Retinal Disorders Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Retinal Disorders Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Retinal Disorders Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Ocular Inflammatory Disease (Uveitis) Image Figure 13. Global Ocular Inflammatory Disease (Uveitis) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Diabetic Retinopathy Image Figure 15. Global Diabetic Retinopathy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Age Related Macular Degeneration Image Figure 17. Global Age Related Macular Degeneration Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Macular Hole Image Figure 19. Global Macular Hole Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Retinal Disorders Therapy Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Retinal Disorders Therapy Market Share by Type 2025 VS 2032 Figure 22. North America Retinal Disorders Therapy Market Size Share by Type (2021-2032) Figure 23. Europe Retinal Disorders Therapy Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Retinal Disorders Therapy Market Size Share by Type (2021-2032) Figure 25. Latin America Retinal Disorders Therapy Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Retinal Disorders Therapy Market Size Share by Type (2021-2032) Figure 27. Hospitals Image Figure 28. Global Hospitals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Clinics Image Figure 30. Global Clinics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Others Image Figure 32. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Retinal Disorders Therapy Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Retinal Disorders Therapy Market Share by Application 2025 VS 2032 Figure 35. North America Retinal Disorders Therapy Market Size Share by Application (2021-2032) Figure 36. Europe Retinal Disorders Therapy Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Retinal Disorders Therapy Market Size Share by Application (2021-2032) Figure 38. Latin America Retinal Disorders Therapy Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Retinal Disorders Therapy Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Retinal Disorders Therapy Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Retinal Disorders Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Retinal Disorders Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Retinal Disorders Therapy Market Share by Country (2021-2032) Figure 45. Europe Retinal Disorders Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Retinal Disorders Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Retinal Disorders Therapy Market Share by Country (2021-2032) Figure 48. Asia-Pacific Retinal Disorders Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Retinal Disorders Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Retinal Disorders Therapy Market Share by Country (2021-2032) Figure 51. Latin America Retinal Disorders Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Retinal Disorders Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Retinal Disorders Therapy Market Share by Country (2021-2032) Figure 54. Middle East & Africa Retinal Disorders Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Retinal Disorders Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Retinal Disorders Therapy Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Ocular Inflammatory Disease (Uveitis)
  • Diabetic Retinopathy
  • Age Related Macular Degeneration
  • Macular Hole
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • ALLERGAN
  • Alimera Sciences
  • Bausch & Lomb
  • Bristol-Myers Squibb
  • Genentech
  • Genzyme
  • Janssen Biotech
  • OCULAR THERAPEUTIX
  • Swedish Orphan Biovitrum
  • UCBCares
  • AbbVie
  • Eyebright Medical
  • Aier Eye Hospital
  • Alcon Holdings, Inc.
  • Huaxia Eye Hospital
  • Kanghong Pharmaceutical
  • Roche
  • Xingqi Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Retinal Disorders Therapy Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Retinal Disorders Therapy Market Size by Region (2021-2032)
  5. 1.4.1 Global Retinal Disorders Therapy Market Size by Region (2021-2026)
  6. 1.4.2 Global Retinal Disorders Therapy Market Size by Region (2027-2032)
  7. 1.5 Key Regions Retinal Disorders Therapy Market Size (2021-2032)
  8. 1.5.1 North America Retinal Disorders Therapy Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Retinal Disorders Therapy Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Retinal Disorders Therapy Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Retinal Disorders Therapy Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Retinal Disorders Therapy Market Size Growth Rate (2021-2032)
2 Retinal Disorders Therapy Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Ocular Inflammatory Disease (Uveitis)
  3. 2.1.2 Diabetic Retinopathy
  4. 2.1.3 Age Related Macular Degeneration
  5. 2.1.4 Macular Hole
  6. 2.2 Global Retinal Disorders Therapy Market Size by Type
  7. 2.2.1 Global Retinal Disorders Therapy Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Retinal Disorders Therapy Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Retinal Disorders Therapy Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Retinal Disorders Therapy Market Size by Regions
  11. 2.3.1 North America Retinal Disorders Therapy Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Retinal Disorders Therapy Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Retinal Disorders Therapy Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Retinal Disorders Therapy Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Retinal Disorders Therapy Market Size Breakdown by Type (2021-2026)
3 Retinal Disorders Therapy Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospitals
  3. 3.1.2 Clinics
  4. 3.1.3 Others
  5. 3.2 Global Retinal Disorders Therapy Market Size by Application
  6. 3.2.1 Global Retinal Disorders Therapy Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Retinal Disorders Therapy Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Retinal Disorders Therapy Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Retinal Disorders Therapy Market Size by Regions
  10. 3.3.1 North America Retinal Disorders Therapy Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Retinal Disorders Therapy Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Retinal Disorders Therapy Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Retinal Disorders Therapy Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Retinal Disorders Therapy Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Retinal Disorders Therapy Industry Trends
  2. 4.2 Retinal Disorders Therapy Industry Drivers
  3. 4.3 Retinal Disorders Therapy Industry Opportunities and Challenges
  4. 4.4 Retinal Disorders Therapy Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Retinal Disorders Therapy Revenue (2021-2026)
  2. 5.2 Global Retinal Disorders Therapy Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Retinal Disorders Therapy Key Company Headquarters & Area Served
  4. 5.4 Global Retinal Disorders Therapy Company, Product Type & Application
  5. 5.5 Global Retinal Disorders Therapy Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Retinal Disorders Therapy Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Retinal Disorders Therapy Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Retinal Disorders Therapy Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 ALLERGAN
  2. 6.1.1 ALLERGAN Company Information
  3. 6.1.2 ALLERGAN Business Overview
  4. 6.1.3 ALLERGAN Retinal Disorders Therapy Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 ALLERGAN Retinal Disorders Therapy Product Portfolio
  6. 6.1.5 ALLERGAN Recent Developments
  7. 6.2 Alimera Sciences
  8. 6.2.1 Alimera Sciences Company Information
  9. 6.2.2 Alimera Sciences Business Overview
  10. 6.2.3 Alimera Sciences Retinal Disorders Therapy Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Alimera Sciences Retinal Disorders Therapy Product Portfolio
  12. 6.2.5 Alimera Sciences Recent Developments
  13. 6.3 Bausch & Lomb
  14. 6.3.1 Bausch & Lomb Company Information
  15. 6.3.2 Bausch & Lomb Business Overview
  16. 6.3.3 Bausch & Lomb Retinal Disorders Therapy Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Bausch & Lomb Retinal Disorders Therapy Product Portfolio
  18. 6.3.5 Bausch & Lomb Recent Developments
  19. 6.4 Bristol-Myers Squibb
  20. 6.4.1 Bristol-Myers Squibb Company Information
  21. 6.4.2 Bristol-Myers Squibb Business Overview
  22. 6.4.3 Bristol-Myers Squibb Retinal Disorders Therapy Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Bristol-Myers Squibb Retinal Disorders Therapy Product Portfolio
  24. 6.4.5 Bristol-Myers Squibb Recent Developments
  25. 6.5 Genentech
  26. 6.5.1 Genentech Company Information
  27. 6.5.2 Genentech Business Overview
  28. 6.5.3 Genentech Retinal Disorders Therapy Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Genentech Retinal Disorders Therapy Product Portfolio
  30. 6.5.5 Genentech Recent Developments
  31. 6.6 Genzyme
  32. 6.6.1 Genzyme Company Information
  33. 6.6.2 Genzyme Business Overview
  34. 6.6.3 Genzyme Retinal Disorders Therapy Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Genzyme Retinal Disorders Therapy Product Portfolio
  36. 6.6.5 Genzyme Recent Developments
  37. 6.7 Janssen Biotech
  38. 6.7.1 Janssen Biotech Company Information
  39. 6.7.2 Janssen Biotech Business Overview
  40. 6.7.3 Janssen Biotech Retinal Disorders Therapy Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Janssen Biotech Retinal Disorders Therapy Product Portfolio
  42. 6.7.5 Janssen Biotech Recent Developments
  43. 6.8 OCULAR THERAPEUTIX
  44. 6.8.1 OCULAR THERAPEUTIX Company Information
  45. 6.8.2 OCULAR THERAPEUTIX Business Overview
  46. 6.8.3 OCULAR THERAPEUTIX Retinal Disorders Therapy Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 OCULAR THERAPEUTIX Retinal Disorders Therapy Product Portfolio
  48. 6.8.5 OCULAR THERAPEUTIX Recent Developments
  49. 6.9 Swedish Orphan Biovitrum
  50. 6.9.1 Swedish Orphan Biovitrum Company Information
  51. 6.9.2 Swedish Orphan Biovitrum Business Overview
  52. 6.9.3 Swedish Orphan Biovitrum Retinal Disorders Therapy Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Swedish Orphan Biovitrum Retinal Disorders Therapy Product Portfolio
  54. 6.9.5 Swedish Orphan Biovitrum Recent Developments
  55. 6.10 UCBCares
  56. 6.10.1 UCBCares Company Information
  57. 6.10.2 UCBCares Business Overview
  58. 6.10.3 UCBCares Retinal Disorders Therapy Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 UCBCares Retinal Disorders Therapy Product Portfolio
  60. 6.10.5 UCBCares Recent Developments
  61. 6.11 AbbVie
  62. 6.11.1 AbbVie Company Information
  63. 6.11.2 AbbVie Business Overview
  64. 6.11.3 AbbVie Retinal Disorders Therapy Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 AbbVie Retinal Disorders Therapy Product Portfolio
  66. 6.11.5 AbbVie Recent Developments
  67. 6.12 Eyebright Medical
  68. 6.12.1 Eyebright Medical Company Information
  69. 6.12.2 Eyebright Medical Business Overview
  70. 6.12.3 Eyebright Medical Retinal Disorders Therapy Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Eyebright Medical Retinal Disorders Therapy Product Portfolio
  72. 6.12.5 Eyebright Medical Recent Developments
  73. 6.13 Aier Eye Hospital
  74. 6.13.1 Aier Eye Hospital Company Information
  75. 6.13.2 Aier Eye Hospital Business Overview
  76. 6.13.3 Aier Eye Hospital Retinal Disorders Therapy Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Aier Eye Hospital Retinal Disorders Therapy Product Portfolio
  78. 6.13.5 Aier Eye Hospital Recent Developments
  79. 6.14 Alcon Holdings, Inc.
  80. 6.14.1 Alcon Holdings, Inc. Company Information
  81. 6.14.2 Alcon Holdings, Inc. Business Overview
  82. 6.14.3 Alcon Holdings, Inc. Retinal Disorders Therapy Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Alcon Holdings, Inc. Retinal Disorders Therapy Product Portfolio
  84. 6.14.5 Alcon Holdings, Inc. Recent Developments
  85. 6.15 Huaxia Eye Hospital
  86. 6.15.1 Huaxia Eye Hospital Company Information
  87. 6.15.2 Huaxia Eye Hospital Business Overview
  88. 6.15.3 Huaxia Eye Hospital Retinal Disorders Therapy Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Huaxia Eye Hospital Retinal Disorders Therapy Product Portfolio
  90. 6.15.5 Huaxia Eye Hospital Recent Developments
  91. 6.16 Kanghong Pharmaceutical
  92. 6.16.1 Kanghong Pharmaceutical Company Information
  93. 6.16.2 Kanghong Pharmaceutical Business Overview
  94. 6.16.3 Kanghong Pharmaceutical Retinal Disorders Therapy Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Kanghong Pharmaceutical Retinal Disorders Therapy Product Portfolio
  96. 6.16.5 Kanghong Pharmaceutical Recent Developments
  97. 6.17 Roche
  98. 6.17.1 Roche Company Information
  99. 6.17.2 Roche Business Overview
  100. 6.17.3 Roche Retinal Disorders Therapy Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Roche Retinal Disorders Therapy Product Portfolio
  102. 6.17.5 Roche Recent Developments
  103. 6.18 Xingqi Pharmaceutical
  104. 6.18.1 Xingqi Pharmaceutical Company Information
  105. 6.18.2 Xingqi Pharmaceutical Business Overview
  106. 6.18.3 Xingqi Pharmaceutical Retinal Disorders Therapy Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Xingqi Pharmaceutical Retinal Disorders Therapy Product Portfolio
  108. 6.18.5 Xingqi Pharmaceutical Recent Developments
7 North America
  1. 7.1 North America Retinal Disorders Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Retinal Disorders Therapy Market Size by Country (2021-2026)
  3. 7.3 North America Retinal Disorders Therapy Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Retinal Disorders Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Retinal Disorders Therapy Market Size by Country (2021-2026)
  3. 8.3 Europe Retinal Disorders Therapy Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Retinal Disorders Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Retinal Disorders Therapy Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Retinal Disorders Therapy Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Retinal Disorders Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Retinal Disorders Therapy Market Size by Country (2021-2026)
  3. 10.3 South America Retinal Disorders Therapy Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Retinal Disorders Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Retinal Disorders Therapy Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Retinal Disorders Therapy Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst